trending Market Intelligence /marketintelligence/en/news-insights/trending/vjre_hyopij5u6l574xoua2 content esgSubNav
In This List

Canntab Therapeutics director resigns

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Canntab Therapeutics director resigns

Canntab Therapeutics Ltd. said Sheldon Inwentash resigned from its board to pursue other opportunities.

The Canada-based company develops advanced pharmaceutical-grade formulations of cannabinoids.